Harleysville, PA, United States of America

William J Smith

This inventor holds 6 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William J Smith. Retrieved from https://idiyas.com/inventor/william-j-smith-apdosiik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 1 (Patent Applications = 10)

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

6 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 2021-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12280107 - Pneumococcal conjugate vaccine formulations (2025-04-21),

2. 12097250 - Compositions comprisingpolysaccharide-protein conjugates and methods of use thereof (2024-09-24),

3. 11850278 - Compositions comprisingpolysaccharide-protein conjugates and methods of use thereof (2023-12-26),

4. 11219680 - Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier (2022-01-11),

5. 11116828 - Compositions comprisingpolysaccharide-protein conjugates and methods of use thereof (2021-09-14),

6. 11090374 - Enhancing immunogenicity ofpolysaccharide-protein conjugates (2021-08-17),

Title: Innovations by William J Smith

Introduction

William J Smith is a notable inventor based in Harleysville, PA, with a significant contribution to the field of immunology. He holds a total of six patents, showcasing his dedication to advancing medical science and public health.

Latest Patents

Among his latest innovations are formulations for pneumococcal conjugate vaccines. These formulations incorporate surfactant systems that utilize polysorbate 20 or a combination of a poloxamer and a polyol. Additionally, he has developed multivalent immunogenic compositions that consist of more than one polysaccharide-protein conjugate. Each conjugate includes a polysaccharide from a specific serotype conjugated to a carrier protein. These compositions are designed to induce a protective immune response in patients and are beneficial in providing protection against infections and diseases caused by pneumococcal bacteria.

Career Highlights

William J Smith is currently associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to focus on innovative solutions that address critical health challenges.

Collaborations

He has collaborated with notable colleagues, including Michael Albert Winters and Patrick McHugh, to further enhance the impact of his research and inventions.

Conclusion

William J Smith's contributions to vaccine formulations and immunogenic compositions reflect his commitment to improving healthcare outcomes. His innovative work continues to play a vital role in the fight against infectious diseases.

Profile summary based on public USPTO records.